Citi Still Expects FDA Approval For Portola Despite 90 Day Delay
December 28, 2017 at 07:39 AM EST
After speaking to management, Citi analyst Yigal Nochomovitz expects Portola Pharmaceuticals' AndexXa to be approved on or before the new FDA action date of May 4, 2018.
